Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan and Forest enter agreement for nebivolol
Under the terms of the agreement, Forest will make an upfront payment to Mylan of $75 million as well as potential future milestone payments. In addition, Mylan will
Under the terms of the agreement, Forest will make an upfront payment to Mylan of $75 million as well as potential future milestone payments. In addition, Mylan will
NicAlert gives a visual read-out of the level of tobacco use or exposure within minutes and requires no instruments to use. NicAlert has received clearance from the FDA
The decision has also fueled speculation that Novartis may be planning a giant bid for Serono SA with shares in the Swiss biotech company rising to a three
TZP-101 is targeted at ghrelin, a peptide hormone secreted by the stomach and small intestine which plays a physiological role in the stimulation of gastrointestinal (GI) motility. Animal
Cephalon will grant Mylan a non-exclusive royalty-bearing right to market and sell a generic version of Provigil in the US from October 2011, unless Cephalon obtains a pediatric
Caprion will contribute a selection of cancer targets that it has discovered using its proprietary CellCarta proteomics technology platform. ImClone Systems will have exclusive, worldwide rights to develop
An orphan drug designation confers a number of benefits including ten years of potential market exclusivity if the product candidate is approved for marketing in the EU, and
The payment was made pursuant to an agreement between the companies reached in October 2004, under which GSK acquired exclusive worldwide rights to develop and commercialize GSK716155 for
Under terms of the agreement, CoGenesys is entitled to an upfront licensing fee, development milestone payments and royalties on future sales of antibody therapeutics developed by PDL against
The primary objective of the study was to determine the safety and tolerability of TACI-Ig in rheumatoid arthritis (RA) patients and to examine the relationship between TACI-Ig dose